Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Franklin Strategic Biotechnology: (MF: FBDIX)

(MF) As of Feb 11, 2016 06:05 PM ET

 Add to portfolio

$114.87 USD

-1.45 (-1.25%)

Is FBDIX a
Buy, Hold or Sell?

See its Zacks Rank in our free fund analysis report.

Get Free Report for FBDIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Dec 31, 2015

Total Return %* Percentile Rank Objective
YTD 5.49 71
3 months 9.90 29
6 months -11.81 84
1 Year 5.50 71
3 Year 33.56 11
5 Year 27.27 10
10 Year 14.99 14

* Annual for three years and beyond.

Zacks Premium Research for FBDIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?]
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 47.53
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 12/31/2015 1,601.91
%Turnover 12/31/2015 41.43

Risk

3 Year 5 Year 10 Year
Beta 1.05 1.01 0.80
Alpha 17.69 14.72 9.38
R Squared 0.23 0.32 0.37
Std. Dev. 23.14 21.06 20.11
Sharpe 1.60 1.42 2.00

Sector / Country Weightings

As of 12/31/2015 % of Portfolio
Health 65.87
Services 16.99
Other 13.03
Technology 2.78
Retail Trade 0.74
Industrial Cyclical 0.44
Energy 0.15

Portfolio Holdings

Top Equity Holdings
(As of 7/31/2015)
% of Portfolio Value (Mil$)
CELGENE CORP 8.77 184.41
GILEAD SCIENCES INC 8.75 183.90
BIOGEN INC 5.58 117.23
AMGEN INC 4.73 99.35
REGENERON PHARMACEUTICALS 3.28 68.94
INCYTE PHARMACEUTICALS IN 3.27 68.67
BIOMARIN PHARMACEUTICAL 2.99 62.92
ILLUMINA INC 2.78 58.49
VERTEX PHARMACEUTICALS IN 2.51 52.76

Stock Holding % of Net Assets

As Of 7/31/2015
Total Issues 121
Avg. P/E 37.34
Avg. P/Book 6.00
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 48,352

Allocation

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 27.53
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 14.78
Foreign Bond 24.97
High Yield Bond 0.00